Associated Papers
Integrating epidemiology and genomics data to estimate the prevalence of acquired cysteine drug targets in the U.S. cancer patient population.
Arun AS et al.
The Pharmacogenomics Journal, 2025
40044654 (PubMed )
Supplement: 41397_2025_364_MOESM3_ESM.xlsx › Sheet1
Therapeutic and prognostic potential of GPCRs in prostate cancer from multi-omics landscape.
Li S et al.
Frontiers in Pharmacology, 2022
Select a paper to view details